There is a huge scandal going on now about atypical antipsychotic drug use in children:

Some links to read:
http://www.ahrp.org/cms/content/view/549/70/

My email box gets mails DAILY about this scandal.
http://bipolarblast.wordpress.com/20...als-were-done/

You can Google this topic and find zillions of pages of information.

The way psychiatrists are informed about new drug treatments is that they attend conferences (in very nice resorts FREE) and other psychiatrists (who are paid for by the drug companies to say positive things) give lectures to encourage the use of the drug that the sponsor of the conference makes.

A psychiatrist from Wyeth explained HIS experience with doing this to the NYTimes:
http://neurotalk.psychcentral.com/sh...ighlight=Wyeth

In fact already, Eli Lilly has to pay out 3.4 BILLION in damages to state Medicaids for misrepresenting Zyprexa. Seroquel is next. Abilify has remained untouched ONLY because it is still the newest. When doctors cannot use the other drugs instead of understanding why, they just prescribe another! (Abilify)

This same convoluted reasoning occurs with NSAIDs... all of them have been shown to affect the health of the heart...
Bextra and Vioxx were taken off the market in fact. Celebrex hangs by a thread. So what do doctors do? They have latched onto Mobic ...which is just as dangerous. Partly due to the sales pitch from the sales people visiting the offices. I believe it is the same for Abilify.

The time is coming for Abilify however, because in the end the truth eventually does come out. It is just unfortunate that people have to suffer while waiting for that truth.
Notice the heavy advertising of Abilify in magazines and television right now. They are battling the generics of Risperdal and Seroquel that the insurance companies mandate. Abilify does not have a generic yet, but soon it will be here. The ads typically come on about 2 yrs before the end of the patent:
Abilify has several dates:
http://www.drugpatentwatch.com/premi...hstring=OTSUKA
But this site claims 2015 as the absolute end of the patent in US:
http://bipolar-disorder.emedtv.com/a...c-abilify.html

Here are some details about the money:
http://www.zacks.com/blog/post_detail.html?t=18862